During its presentation at the J.P. Morgan Healthcare Conference, Bruker provided initial guidance for 2023 for organic revenue growth up mid-to-high single digit percent year-over-year.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BRKR: